UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 187

Sortiert nach

Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer

Oncogenesis (New York, NY), 2017-10, Vol.6 (10), p.e385-e385

2017

Link zum Volltext

Verfügbarkeit prüfen

Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery

European journal of surgical oncology, 2016-04, Vol.42 (4), p.481-488

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of eribulin as first- or second-line treatment for patients with recurrent HER2-negative breast cancer: A phase II randomized study (JBCRG-19)

Annals of oncology, 2018-10, Vol.29, p.viii101-viii101

2018

Link zum Volltext

Verfügbarkeit prüfen

Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

Breast (Edinburgh), 2017-03, Vol.32, p.S79-S79

2017

Link zum Volltext

Verfügbarkeit prüfen

P131 Targeted ultrasonography for MRI-detected lesions of preoperative breast cancer patients

Breast (Edinburgh), 2015-03, Vol.24, p.S70-S70

2015

Link zum Volltext

Verfügbarkeit prüfen

P237 The impact of body composition change on neo-adjuvant chemotherapy for breast cancer patients

Breast (Edinburgh), 2015-03, Vol.24, p.S106-S107

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-07-23: The quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcome after chemotherapy for patients with early-stage breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-07-23

2018

Link zum Volltext

Verfügbarkeit prüfen

46O Neratinib + capecitabine (N+C) vs lapatinib + capecitabine (L+C) in Asians with HER2+ metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial

Annals of oncology, 2020-11, Vol.31, p.S1259-S1259

2020

Link zum Volltext

Verfügbarkeit prüfen

Immediate partial breast reconstruction with chest wall perforator flaps

European journal of cancer (1990), 2018-04, Vol.92, p.S80-S81

2018

Link zum Volltext

Verfügbarkeit prüfen

297 (PB-092) - Immediate partial breast reconstruction with chest wall perforator flaps

European journal of cancer (1990), 2018-04, Vol.92, p.S80-S81

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-13-09: Sequential second line endocrine therapy is still an effective strategy for postmenopausal ER+ and HER2- advanced breast cancer with low sensitivity to initial endocrine therapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-13-09

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-07-15: The outcomes for super elderly patients over 80 years old after breast cancer surgery

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-07-15

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT1-05-04: Phase 3 trial of ca rboplatin in t riple negative breast cancer (TNBC) patients with residual invasive carcinoma after neoadjuvant chemotherapy ( J ONIE4:J-CAT trial)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-05-04-OT1-05-04

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Characterization of Bone Marrow–Derived Fibroblasts Recruited into Fibrotic Lesions

Stem cells (Dayton, Ohio), 2005-05, Vol.23 (5), p.699-706

2005

Link zum Volltext

Verfügbarkeit prüfen

Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction

Biochemical and biophysical research communications, 2003-09, Vol.309 (1), p.232-240

2003

Link zum Volltext

Verfügbarkeit prüfen

P167 - Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

Breast (Edinburgh), 2017-03, Vol.32, p.S79-S79

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-09-25: Exploring immunomodulatory effects of zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-09-25

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-11-03: Site-Specific, Concomitant Delivery of Rapamycin and Paclitaxel in Breast Cancer: Consequent Synergistic Efficacy Enhancement

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-11-03

2012

Link zum Volltext

Verfügbarkeit prüfen

Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (17), p.6252-6258

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-11-11: Multistage Delivery of Paclitaxel: Increased Drug Stability and Sustained Release Results in Enhanced Efficacy in Breast Cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-11-11

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow‐derived endothelial cells and myofibroblasts in cancer‐induced stroma

International journal of cancer, 2005-07, Vol.115 (6), p.885-892

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-14-10: Treatment of Breast Cancer Using Multistage Delivery of PI3K/mTOR Inhibitors

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-14-10

2010

Link zum Volltext

Verfügbarkeit prüfen

Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers

Clinical cancer research, 2005-05, Vol.11 (9), p.3494-3502

2005

Link zum Volltext

Verfügbarkeit prüfen

In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma

International journal of cancer, 2005-11, Vol.117 (2), p.212-220

2005

Link zum Volltext

Verfügbarkeit prüfen

Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma

International journal of cancer, 2005-10, Vol.116 (6), p.876-884

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(172)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer

Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery

Clinical efficacy of eribulin as first- or second-line treatment for patients with recurrent HER2-negative breast cancer: A phase II randomized study (JBCRG-19)

Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

P131 Targeted ultrasonography for MRI-detected lesions of preoperative breast cancer patients

P237 The impact of body composition change on neo-adjuvant chemotherapy for breast cancer patients

Abstract P1-07-23: The quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcome after chemotherapy for patients with early-stage breast cancer

46O Neratinib + capecitabine (N+C) vs lapatinib + capecitabine (L+C) in Asians with HER2+ metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial

Immediate partial breast reconstruction with chest wall perforator flaps

297 (PB-092) - Immediate partial breast reconstruction with chest wall perforator flaps

Abstract P4-13-09: Sequential second line endocrine therapy is still an effective strategy for postmenopausal ER+ and HER2- advanced breast cancer with low sensitivity to initial endocrine therapy

Abstract P1-07-15: The outcomes for super elderly patients over 80 years old after breast cancer surgery

Abstract OT1-05-04: Phase 3 trial of ca rboplatin in t riple negative breast cancer (TNBC) patients with residual invasive carcinoma after neoadjuvant chemotherapy ( J ONIE4:J-CAT trial)

In Vivo Characterization of Bone Marrow–Derived Fibroblasts Recruited into Fibrotic Lesions

Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction

P167 - Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

Abstract P4-09-25: Exploring immunomodulatory effects of zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study

Abstract P6-11-03: Site-Specific, Concomitant Delivery of Rapamycin and Paclitaxel in Breast Cancer: Consequent Synergistic Efficacy Enhancement

Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors

Abstract P6-11-11: Multistage Delivery of Paclitaxel: Increased Drug Stability and Sustained Release Results in Enhanced Efficacy in Breast Cancer

Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow‐derived endothelial cells and myofibroblasts in cancer‐induced stroma

Abstract P6-14-10: Treatment of Breast Cancer Using Multistage Delivery of PI3K/mTOR Inhibitors

Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers

In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma

Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma

Suchergebnisse filtern